Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

NCT01163526 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01163526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01163526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
September 30, 2010
Completion date
July 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain (nervous system) cancers, colon cancer, colon/rectal cancer, hepatobiliary cancers, hepatocellular carcinoma (hepatoma), liver, neuroendocrine tumors